Blanket Purchase Agreement V797D70066-36C25724A0020
- The U.S. Department of Veterans Affairs (VA), through its Veterans Integrated Service Network (VISN) 19, has awarded a series of Blanket Purchase Agreement (BPA) call contracts to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services and cancer testing. The contracts, valued at over $500,000 total, are for the provision of MDX health testing and analysis services to support the VA's healthcare programs for veterans. The contracts were awarded under the...
- This Blanket Purchase Agreement (BPA) is a single-award federal contract vehicle awarded by the Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The contract, with a ceiling value of $480,000, is for the provision of DX Prostate Testing services to the Veterans Integrated Service Network (VISN) 17 over a performance period ending on January 9, 2030. Mdxhealth has been awarded...
- This Blanket Purchase Agreement (BPA) is a single-award federal contract vehicle administered by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to procure cancer diagnostic testing services from MdxHealth, Inc., a for-profit healthcare company. The BPA calls for MdxHealth to provide its MDXHEALTH GPS molecular diagnostic services, which utilize genetic and epigenetic biomarkers to support personalized diagnosis and treatment for various cancers...
- This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company based in Irvine, California. The contract, valued at up to $755,655.00, is for the provision of prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The BPA has a period of performance from July 1, 2022 through...
- This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to Mdxhealth, Inc., a for-profit healthcare company specializing in cancer diagnostics. The BPA, with a total ceiling value of $4,800,000, is for the provision of Oncotype DX prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The period of performance...
- The federal contract IDV award is a single-award Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 19 (VISN 19) to MDXHealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The $1,424,021.22 BPA, awarded on October 1, 2025 with a performance period through September 30, 2030, enables VISN 19 to efficiently procure MDXHealth's specialized cancer diagnostic...
- This federal contract Indefinite Delivery Vehicle (IDV) is a Multiple Award Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company. The contract, valued at up to $3,194,250.75, is for the provision of medical laboratory testing and analysis services, with a specific focus on advanced molecular diagnostic testing for cancer. Mdxhealth offers specialized genetic and epigenetic testing services such as...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 1 to Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation. The single-award BPA, valued at $1,352,736, will provide the VA's VISN 1 facilities with an estimated 1,800 ExoDx Prostate (IntelliScore) tests over a five-year period. The ExoDx Prostate test is a non-invasive, urine-based liquid biopsy that analyzes exosomal RNA biomarkers to assess...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Veterans Health Administration (VHA) to Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division. The BPA has a total ceiling value of $335,800 and is for the provision of Oncotype DX cancer testing services, including gene expression profiling and genomic testing, to support federal healthcare programs. The contract utilizes Exact Sciences' Federal Supply...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Exact Sciences Corporation, a for-profit medical technology company. The contract, valued at $919,774.30, is for the provision of Genomic Health genetic testing services, primarily the Oncotype DX gene expression profiling test, to VISN 19 healthcare facilities. The contract utilizes the Medical Laboratory Testing and Analysis Services (FSS-621-II)...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- V797D70066Federal Supply Schedule
- V797D70066-36C25724A0020Blanket Purchase Agreement
- 2Federal Contract Awards
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Mdxhealth, Inc., a for-profit healthcare company, for the provision of specialized cancer diagnostic testing services. The BPA is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract (FSS-621-II) and has a total potential value of $280,000 with an ultimate completion date of April 2, 2029. Specifically, the BPA covers DX Prostate Testing, Oncotype Prostate Cancer Testing, and other advanced genomic cancer screening services such as ConfirmMDx and SelectMDx testing. This allows the VA to efficiently procure these specialized testing services from Mdxhealth over multiple years to support quality healthcare for veterans across its national network of hospitals and clinics. The contract has no set-aside designation and the services will be delivered at Mdxhealth's facility in Irvine, California. This BPA award builds upon Mdxhealth's existing portfolio of federal contracts and Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles with the VA to provide advanced molecular diagnostic capabilities that aid in the diagnosis and treatment of cancer.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $0 | 2/12/25 | |
| Not listed | Not listed | $0 | 3/21/24 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36C25724A0020-36C25725N0212 | Mdxhealth, Inc. | $27.7k | 4/3/25 | 4/2/26 | 2/12/25 | |
BPA Call 36C25724A0020-36C25724N0276 | Mdxhealth, Inc. | $9.6k | 4/3/24 | 4/2/25 | 8/11/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Q301--Oncotype DX Prostate Testing | 36C25724Q0387 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Special Notice 1/1 | 2/21/24, 3:19 PM |